Another week has passed without any major ERISA rulings from the federal courts. There was still plenty of action, however, including: (1) a ruling that a multiemployer health fund does not have to arbitrate its claims against its administrator over the administrator’s alleged mishandling of claims (Aetna v. Board of Trustees); (2) final
While there was no notable decision this week, plenty of interesting issues percolated through the federal courts. Read on for the following: (1) the latest installment in the legal war between pharmacy benefit managers and the State of Arkansas over that state’s efforts to rein them in (Central States v. McClain); (2) the
It was another slow-ish week in ERISA-land, so we have no notable decision to highlight. However, read on to learn more about how (1) a wrongful death claim prompted by an astronomical increase in the price of an asthma inhaler is not preempted by ERISA (Schmidtknecht v. OptumRx Inc.), (2) pharmacy benefit managers have